home / stock / gbio / gbio quote
Last: | $4.07 |
---|---|
Change Percent: | 0.0% |
Open: | $3.72 |
Close: | $4.07 |
High: | $4.29 |
Low: | $3.72 |
Volume: | 442,530 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.07 | $3.72 | $4.07 | $4.29 | $3.72 | 442,530 | 03-29-2024 |
$4.07 | $3.72 | $4.07 | $4.29 | $3.72 | 441,898 | 03-28-2024 |
$3.7 | $3.26 | $3.7 | $3.73 | $3.23 | 335,417 | 03-27-2024 |
$3.17 | $3.29 | $3.17 | $3.33 | $3.14 | 168,044 | 03-26-2024 |
$3.21 | $3.33 | $3.21 | $3.4 | $3.15 | 135,965 | 03-25-2024 |
$3.33 | $3.33 | $3.33 | $3.48 | $3.265 | 200,004 | 03-22-2024 |
$3.34 | $3.24 | $3.34 | $3.4099 | $3.175 | 232,250 | 03-21-2024 |
$3.22 | $2.98 | $3.22 | $3.24 | $2.97 | 168,505 | 03-20-2024 |
$2.97 | $2.96 | $2.97 | $3 | $2.81 | 126,082 | 03-19-2024 |
$2.96 | $3.11 | $2.96 | $3.11 | $2.9463 | 139,573 | 03-18-2024 |
$3.09 | $2.93 | $3.09 | $3.12 | $2.86 | 480,735 | 03-15-2024 |
$2.97 | $3 | $2.97 | $3 | $2.835 | 139,632 | 03-14-2024 |
$3 | $3.1 | $3 | $3.1765 | $2.9 | 296,701 | 03-13-2024 |
$3.1 | $3.21 | $3.1 | $3.315 | $3.0501 | 416,994 | 03-12-2024 |
$3.2 | $3.51 | $3.2 | $3.705 | $3.145 | 448,810 | 03-11-2024 |
$3.51 | $3.01 | $3.51 | $3.68 | $3.01 | 516,962 | 03-08-2024 |
$2.95 | $2.7 | $2.95 | $3.01 | $2.6317 | 217,243 | 03-07-2024 |
$2.77 | $2.92 | $2.77 | $2.92 | $2.68 | 183,482 | 03-06-2024 |
$2.86 | $2.71 | $2.86 | $2.92 | $2.7 | 255,737 | 03-05-2024 |
$2.76 | $2.68 | $2.76 | $2.83 | $2.68 | 340,031 | 03-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Generation Bio Co. Company Name:
GBIO Stock Symbol:
NASDAQ Market:
- Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia - Development of breakthrough immune-quiet DNA for hemophilia A program continues - Cash balance of $264.4 mil...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (NASDAQ:GBIO) a biotechnology company innovating genetic medicines for pe...